|
FY2025
12 months to Dec 28, 2025
|
FY2024
12 months to Dec 29, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Jan 1, 2023
|
FY2021
12 months to Jan 2, 2022
|
|
|---|---|---|---|---|---|
| CASH FLOWS PROVIDED BY OPERATING ACTIVITIES: | |||||
| Net (loss)/income | |||||
| Adjustments to reconcile net (loss)/income to net cash provided by operating activities: | |||||
| Depreciation and amortization expense | |||||
| Deferred and other income taxes | |||||
| Goodwill impairment | |||||
| Loss on extinguishment of debt | |||||
| Long-lived asset impairment and lease termination charges | |||||
| Loss on disposal of property and equipment | |||||
| Loss/(gain) on divestiture of Insomnia Cookies | |||||
| Gain on refranchising | |||||
| Gain on remeasurement of equity method investment | |||||
| Gain on sale-leaseback | |||||
| Share-based compensation | |||||
| Change in accounts and notes receivable allowances | |||||
| Inventory write-off | |||||
| Settlement of interest rate swap derivatives | |||||
| Amortization related to settlement of interest rate swap derivatives | |||||
| Other | |||||
| Change in operating assets and liabilities, excluding business acquisitions and divestitures, and foreign currency translation adjustments: | |||||
| Accounts, notes, and taxes receivable | |||||
| Inventories | |||||
| Other current and noncurrent assets | |||||
| Operating lease assets and liabilities | |||||
| Accounts payable and accrued liabilities | |||||
| Other long-term obligations and deferred credits | |||||
| Net cash provided by operating activities | |||||
| CASH FLOWS (USED FOR)/PROVIDED BY INVESTING ACTIVITIES: | |||||
| Purchase of property and equipment | |||||
| Proceeds from disposals of assets | |||||
| Proceeds from sale-leaseback | |||||
| Acquisition of shops and franchise rights from franchisees, net of cash acquired | |||||
| Purchase of equity method investment | |||||
| Net proceeds from divestiture of Insomnia Cookies | |||||
| Principal payment received from loan to Insomnia Cookies | |||||
| Principal payments received from loans to franchisees | |||||
| Disbursement for loan receivable | |||||
| Maturities of held-to-maturity debt securities | |||||
| Net cash (used for)/provided by investing activities | |||||
| CASH FLOWS (USED FOR)/PROVIDED BY FINANCING ACTIVITIES: | |||||
| Proceeds from the issuance of debt | |||||
| Repayment of long-term debt and lease obligations | |||||
| Payment of financing costs | |||||
| Proceeds from structured payables | |||||
| Payments on structured payables | |||||
| Payment of contingent consideration related to a business combination | |||||
| Capital contribution from shareholders, net of loans issued | |||||
| Proceeds from IPO, net of underwriting discounts (excluding unpaid issuance costs) | |||||
| Payments of issuance costs in connection with initial public offering | |||||
| Proceeds from sale of noncontrolling interest in subsidiary | |||||
| Distribution to shareholders | |||||
| Payments for repurchase and retirement of common stock | |||||
| Distribution to noncontrolling interest | |||||
| Net cash (used for)/provided by financing activities | |||||
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | |||||
| Net increase/(decrease) in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash at beginning of the fiscal year | |||||
| Cash, cash equivalents and restricted cash at end of the fiscal year | |||||
| Supplemental schedule of non-cash investing and financing activities: | |||||
| (Decrease)/increase in accrual for property and equipment | |||||
| Stock issuance under shareholder notes | |||||
| Accrual for distribution to shareholders | |||||
| Reconciliation of cash, cash equivalents and restricted cash at end of fiscal year: | |||||
| Cash and cash equivalents | |||||
| Restricted cash | |||||
Loading...